Streetbeat News

OWLT

Owlet, Inc.

https://owletcare.com

Industry

Medical - Devices

Owlet, Inc. operates as a digital parenting platform in the United States. The company's platform focuses on giving real-time data and insights to parents. Its products include Smart Sock, a baby monitor to track an infant's oxygen levels, heart rates, and sleep trends; Dream Sock, an app to assist children for better sleep; Cam, a video streaming app to hear and see baby from anywhere; and Dream Lab, an interactive online platform that assists families in building healthy sleep habits. The company also offers Dream Duo, a monitoring system for baby's sleeping habits and includes wearable sock monitor, HD video, and digital sleep coach. Owlet, Inc. was founded in 2012 and is based in Lehi, Utah.

Open

5.00

Mkt cap

79M

Volume

29K

High

5.11

P/E Ratio

-2.87

52-wk high

7.50

Low

4.85

Div yield

N/A

52-wk low

3.20

Owlet, Inc. (OWLT) held its Q3 2024 earnings call, discussing financial results and company updates. Key participants included CEO Kurt Workman and CFO Amanda Twede Crawford.

Portfolio Pulse from

November 14, 2024 | 2:30 am

Owlet, Inc. (NYSE: OWLT) will participate in two upcoming investor conferences: the Sidoti Micro Cap Conference and the BTIG Digital Health Forum. This participation may provide insights into the company's future strategies and performance.

Portfolio Pulse from

November 07, 2024 | 9:30 pm

Owlet has regained compliance with the New York Stock Exchange (NYSE) listing requirements, which is a positive development for the company and its investors.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 8:24 pm

Owlet's stock is trading lower following the announcement of a $46.6 million share offering, pricing 3,135,136 shares at $3.70 each.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 11:51 am

Owlet has priced a public offering of 3,135,136 shares at $3.70 each and completed debt refinancing, expecting total proceeds of up to $46.6 million. The company anticipates $11.6 million from the public offering and up to $35 million from debt refinancing.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2024 | 7:00 am

Owlet plans a public offering of its Class A common stock, with an option for underwriters to purchase an additional 15%. Proceeds will be used for general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

September 11, 2024 | 9:24 pm

Owlet has launched its medically-certified Dream Sock in Europe, expanding its market reach. The announcement was made at Kind + Jugend 2024, indicating a strategic move to increase global availability.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 1:42 pm

Owlet expects FY24 net revenue to be between $72.5M and $77.5M, with an estimate of $74.41M. For the second half of 2024, the company projects net revenue between $37M and $42M, gross margins of 46% to 50%, and an Adjusted EBITDA loss ranging from ($3) million to break-even.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 8:57 pm

Owlet (NYSE:OWLT) reported Q2 sales of $20.7 million, surpassing the analyst estimate of $18.5 million by 11.89%. This marks a 58.02% increase from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 8:33 pm

Owlet shares are trading higher following the company's Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 8:27 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.